Displaying 23 projects/programmes
Alzheimer's disease apolipoprotein pathology for treatment elucidation and development
Organising mechanistic knowledge about neurodegenerative diseases for the improvement of drug development and therapy
Amyloid imaging to prevent Alzheimer’s disease
Big Data for Better Outcomes
European Medical Information Framework
European prevention of Alzheimer’s dementia consortium
European Quality In Preclinical Data
Understanding chronic pain and improving its treatment
Identifying digital endpoints to assess fatigue, sleep and activities in daily living in neurodegenerative disorders and immune-mediated inflammatory diseases
Investigating mechanisms and models predictive of accessibility of therapeutics (IM2PACT) into the brain
Improving the care of patients suffering from acute or chronic pain
Inhibiting misfolded protein propagation in neurodegenerative diseases
Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement
Models of patient engagement for Alzheimer’s disease
Efficiently networking European neurodegeneration research
Parkinson disease with mild cognition impairment treated with nicotinic agonist drug
PD-MitoQUANT – A quantitative approach towards the characterisation of mitochondrial dysfunction in Parkinson's disease
Inflammation and AD: modulating microglia function - focussing on TREM2 and CD33
Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development
Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in AD, SZ, and MD
Remote assessment of disease and relapse – Alzheimer’s disease
Remote Assessment of Disease and Relapse in Central Nervous System Disorders
Real world outcomes across the AD spectrum for better care: multi-modal data access platform